May Tun Saung

2PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 05, 2026
FDA Approval Summary: Retifanlimab for the treatment of adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal.

|Apr 11, 2022
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma.

Jianxin Wang, May Tun Saung, Keyu Li

Pageof 1

Frequent Collaborators

1 joint publications

Jianxin Wang

1 joint publications

Keyu Li

1 joint publications

Juan Fu

1 joint publications

Kenji Fujiwara

1 joint publications

Nan Niu

1 joint publications

Stephen Muth

1 joint publications

Junke Wang

1 joint publications

Yao Xu

1 joint publications

Noah Rozich

1 joint publications

Haley Zlomke

Frequent Collaborators

1 joint publications

Jianxin Wang

1 joint publications

Keyu Li

1 joint publications

Juan Fu

1 joint publications

Kenji Fujiwara

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us